In vivo biology of mammalian L1 retrotransposition

哺乳动物 L1 逆转录转座的体内生物学

基本信息

  • 批准号:
    10367362
  • 负责人:
  • 金额:
    $ 40.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-12 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Long Interspersed Nuclear Elements (LINEs) are a class of retrotransposable elements that continually mutate genomes, including mammalian genomes. The currently active family of LINEs in mammals is called LINE-1 (L1). There are hundreds of thousands of copies of L1 in mammalian genomes, and unchecked expression of this element in humans and/or model organisms is associated with various abnormal states, such as cancer, infertility, aging and neurologic disease. We do not know whether L1 plays a causative role in these disorders, partly because our knowledge of L1 biology in vivo is rudimentary, which has limited our ability to experimentally manipulate endogenous L1 activity in a specific manner. Although a number of cellular host factors that can alter L1 retrotransposition have been identified from biochemical pulldowns and genetic screens in immortalized cell lines, the in vivo biological relevance of these factors in the evolutionarily relevant germ cells is unclear. Previously our lab discovered that the endosomal sorting complex required for transport (ESCRT) plays a critical role for productive LINE retrotransposition in both yeast and human tissue culture. This proposal will use mouse genetics to examine whether ESCRT is used for L1 intracellular trafficking and retrotransposition in the male germ line, and whether disruption of the ESCRT/L1 interaction can alleviate germ line defects found in a mouse models of infertility. To this end, we will utilize both wild type mice and mice with known increases in L1 expression in the germline. Mice deleted in the gene for Maelstrom (Mael-/-) have massive overexpression of L1, arrest in meiotic prophase I, and are male sterile. Maelstrom is involved in the biogenesis of small RNAs in the germ line, called piRNAs, and similar transposon/infertility defects are seen when related piRNA biogenesis genes (e.g. Mov10l1) are knocked out in mice. It is currently unknown whether L1 is a driving factor of infertility in these mice. To reduce L1 activity, we will introduce an ALIX knockout allele (ALIX is a component of the ESCRT complex). In Aim 1 we will evaluate germ line L1 RNP localization, regulation, and retrotransposition when the L1/ESCRT interaction is disrupted. In Aim 2 we will determine the contribution of L1 overexpression to germ cell phenotypes in mice. This project will provide valuable insight into whether ESCRT enables L1 RNP trafficking in the germ line. The proposed work will also shed light on whether excess L1 retrotransposition is a driving factor responsible for infertility in piRNA pathway mutants. Because L1 and the piRNA pathway are conserved in humans, and mutations in piRNA pathway genes have been associated with human infertility, we expect that this work will form the basis for future study on the relation between transposon regulation and some cases of human male infertility.
项目概要 长散布核元件 (LINE) 是一类不断突变的逆转录转座元件 基因组,包括哺乳动物基因组。目前哺乳动物中活跃的 LINE 家族称为 LINE-1 (L1)。哺乳动物基因组中有数十万个 L1 拷贝,且未受控制的表达 人类和/或模型生物体内的这种元素与各种异常状态有关,例如癌症、 不孕症、衰老和神经系统疾病。我们不知道 L1 是否在这些疾病中起着致病作用, 部分原因是我们对体内 L1 生物学的了解还很初级,这限制了我们进行实验的能力 以特定方式操纵内源性 L1 活性。尽管许多细胞宿主因素可以改变 L1 逆转录转座已从永生化细胞的生化下拉和遗传筛选中鉴定出来 线,这些因素在进化相关的生殖细胞中的体内生物学相关性尚不清楚。 此前,我们的实验室发现运输所需的内体分选复合物 (ESCRT) 起着至关重要的作用。 生产性 LINE 逆转录转座在酵母和人体组织培养中的作用。本提案将使用鼠标 遗传学检查 ESCRT 是否用于男性的 L1 细胞内运输和逆转录转座 种系,以及破坏 ESCRT/L1 相互作用是否可以减轻小鼠中发现的种系缺陷 不孕不育模型。为此,我们将利用野生型小鼠和已知 L1 增加的小鼠 在种系中表达。 Maelstrom (Mael-/-) 基因缺失的小鼠 L1 大量过度表达, 停滞于减数分裂前期 I,并且是雄性不育的。 Maelstrom 参与小 RNA 的生物合成 种系,称为 piRNA,当相关 piRNA 生物发生时,会看到类似的转座子/不育缺陷 小鼠体内的基因(例如 Mov10l1)被敲除。目前尚不清楚L1是否是不孕不育的驱动因素 在这些老鼠身上。为了减少 L1 活性,我们将引入 ALIX 敲除等位基因(ALIX 是 ESCRT 复合体)。在目标 1 中,我们将评估种系 L1 RNP 定位、调节和逆转录转座 当 L1/ESCRT 相互作用被破坏时。在目标 2 中,我们将确定 L1 过度表达对 小鼠生殖细胞表型。该项目将为 ESCRT 是否支持 L1 RNP 提供有价值的见解 贩运种系。拟议的工作还将阐明过量的 L1 逆转录转座是否是一种 piRNA 途径突变体中导致不孕的驱动因素。因为 L1 和 piRNA 途径是 piRNA 通路基因在人类中保守,并且 piRNA 通路基因的突变与人类不孕不育有关,我们 期望这项工作能够为未来研究转座子调控与某些基因之间的关系奠定基础。 人类男性不育症案例。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffrey S Han其他文献

Jeffrey S Han的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffrey S Han', 18)}}的其他基金

In vivo biology of mammalian L1 retrotransposition - supplement
哺乳动物 L1 逆转录转座的体内生物学 - 补充
  • 批准号:
    10578990
  • 财政年份:
    2022
  • 资助金额:
    $ 40.39万
  • 项目类别:
In vivo biology of mammalian L1 retrotransposition
哺乳动物 L1 逆转录转座的体内生物学
  • 批准号:
    10549834
  • 财政年份:
    2022
  • 资助金额:
    $ 40.39万
  • 项目类别:
Biology of LINE retrotransposition
LINE 逆转录转座的生物学
  • 批准号:
    9980955
  • 财政年份:
    2017
  • 资助金额:
    $ 40.39万
  • 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
  • 批准号:
    8499365
  • 财政年份:
    2010
  • 资助金额:
    $ 40.39万
  • 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
  • 批准号:
    8101968
  • 财政年份:
    2010
  • 资助金额:
    $ 40.39万
  • 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
  • 批准号:
    8294975
  • 财政年份:
    2010
  • 资助金额:
    $ 40.39万
  • 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
  • 批准号:
    7985631
  • 财政年份:
    2010
  • 资助金额:
    $ 40.39万
  • 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
  • 批准号:
    8775361
  • 财政年份:
    2010
  • 资助金额:
    $ 40.39万
  • 项目类别:
Using budding yeast to study LINE (L1) retrotransposition
使用芽殖酵母研究 LINE (L1) 逆转录转座
  • 批准号:
    8686000
  • 财政年份:
    2010
  • 资助金额:
    $ 40.39万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 40.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了